
The study evaluates the effect of serial intralesional steroid injections (ILSIs) on recurrence risk in idiopathic subglottic stenosis (iSGS) patients. Analysis of 75 patients over 1-4 years showed that ILSIs significantly reduced the risk of recurrence, both in time-to-first recurrence and overall recurrence rates. The median time to recurrence was longer in patients who received ILSIs (2.5 years vs. 1.4 years). The findings support ILSIs as an effective adjunct therapy in iSGS.
Like
Save
Share